files/journal/2022-09-03_18-51-40-000000_599.png

Research Journal of Medical Sciences

ISSN: Online 1993-6095
ISSN: Print 1815-9346

References

  1. COVID-19 India Update., 2021. Ministry of Health and Family Welfare, Government of India. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, 0 Vol. 0. 0 1-10.
  2. Koller, C.N., C.J. Schwerzmann, A.S.A. Lang, E. Alexiou and J. Krishnakumar, 2021. Addressing Different Needs: The Challenges Faced by India as the Largest Vaccine Manufacturer While Conducting the World’s Biggest COVID-19 Vaccination Campaign. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Epidemiologia, 2: 1-10.
  3. Andre, F., R. Booy, H. Bock, J. Clemens and S. Datta et al., 2008. Vaccination greatly reduces disease, disability, death and inequity worldwide. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Bull. World Health Org.ization, 86: 1-10.
  4. Thomas, S.J., E.D. Moreira, N. Kitchin, J. Absalon and A. Gurtman et al., 2021. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, New Engl. J. Med., 385: 1-10.
  5. World Health Organization., 2015. Report of the SAGE Working Group on Vaccine Hesitancy.  0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, 0 Vol. 0. 0 1-10.
  6. World Health Organization., 2019.  Ten threats to global health in 2019. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, 0 Vol. 0. 0 1-10.
  7. Dror, A.A., N. Eisenbach, S. Taiber, N.G. Morozov and M. Mizrachi et al., 2020. Vaccine hesitancy: The next challenge in the fight against COVID-19. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Eur. J. Epidemiol., 35: 1-10.
  8. MacDonald, N.E., 2015. Vaccine hesitancy: Definition, scope and determinants. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Vaccine, 33: 1-10.
  9. Lazarus, J.V., S.C. Ratzan, A. Palayew, L.O. Gostin and H.J. Larson et al., 2021. A global survey of potential acceptance of a COVID-19 vaccine. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Nat. Med., 27: 1-10.
  10. Agarwal, S.K. and M. Naha, 2023. COVID-19 Vaccine Coverage in India: A District-Level Analysis. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Vaccines, Vol. 11. 10.3390/vaccines11050948 1-10.
  11. Dubé, E., C. Laberge, M. Guay, P. Bramadat, R. Roy and J.A. Bettinger, 2013. Vaccine hesitancy: an overview. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Hum. Vaccines & Immunotherapeutics, 9: 1-10.
  12. Larson, H.J., C. Jarrett, W.S. Schulz, M. Chaudhuri and Y. Zhou et al., 2015. Measuring vaccine hesitancy: The development of a survey tool. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Vaccine, 33: 1-10.
  13. Young, B., M. Kotzur, L. Gatting, C. Bonner and J. Ayre et al., 2021. The impact of theory-based messages on COVID-19 vaccination intentions: A structured summary of a study protocol for a randomised controlled trial. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Trials, Vol. 22. 10.1186/s13063-021-05277-7 1-10.
  14. Reichelt, M., J.P. Cullen, S. Mayer-Fried, H.A. Russell, N.M. Bennett and R. Yousefi-Nooraie, 2023. Addressing COVID-19 vaccine hesitancy in rural communities: A case study in engaging trusted messengers to pivot and plan. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Front. Public Health, Vol. 11. 10.3389/fpubh.2023.1059067 1-10.
  15. Thompson, M.G., J.L. Burgess, A.L. Naleway, H. Tyner and S.K. Yoon et al., 2021. Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, New Engl. J. Med., 385: 1-10.
  16. Polack, F.P., S.J. Thomas, N. Kitchin, J. Absalon and A. Gurtman et al., 2020. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, New Engl. J. Med., 383: 1-10.
  17. Zheng, C., W. Shao, X. Chen, B. Zhang, G. Wang and W. Zhang, 2022. Real-world effectiveness of COVID-19 vaccines: A literature review and meta-analysis. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Int. J. Infect. Dis., 114: 1-10.
  18. Tenforde M.W., S.S. Kim and C.J. Lindsell, et al., 2020.  Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March-June 2020. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, MMWR Morb Mortal Wkly Rep., 69: 1-10.
  19. Blomberg B., K.G. Mohn and K.A. Brokstad, et al., 2021.  Long COVID in a prospective cohort of home-isolated patients.   0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Nat Med., 27: 1-10.
  20. Larson, H.J., C. Jarrett, E. Eckersberger, D.M.D. Smith and P. Paterson, 2014. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: A systematic review of published literature, 2007–2012. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Vaccine, 32: 1-10.